ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
Dow Jones
42,992.21
-0.77%
US Dollar vs MXN
20.3806
0.28%
Brent Oil
73.845
0.30%
Bitcoin
93,542.24
0.02%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Aura Biosciences Inc (AURA) Cotización

Aura Biosciences Inc

Aura Biosciences Inc (AURA)

Aura Energy Limited
8.33
-0.08
(-0.95%)
Cerrado 29 Diciembre 3:00PM
Delayed by 15 minutes
8.33
0.00
(0.00%)
Fuera de horario: 5:51PM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
8.33
Postura de Compra
7.55
Postura de Venta
17.40
Volume Operado de la Acción
106,307
8.115 Rango del Día 8.50
6.63 Rango de 52 semanas 12.3782
Capitalización de Mercado [m]
416.096M
Precio Anterior
8.41
Precio de Apertura
8.39
Hora
86
@
8.33
Última hora de negociación
Volumen financiero
US$ 880,415
Precio Promedio Ponderado
8.2818
Volumen promedio (3 m)
214,358
Acciones en circulación
49,951,466
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-5.45
Beneficio por acción (BPA)
-1.53
turnover
-
Beneficio neto
-76.41M

Acerca de Aura Biosciences Inc

Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.aurabiosciences.com
Sede
Wilmington, Delaware, USA
Fundado
-
Aura Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker AURA. The last closing price for Aura Biosciences was US$8.41. Over the last year, Aura Biosciences shares have traded in a share price range of US$ 6.63 to US$ 12.3782.

Aura Biosciences currently has 49,951,466 shares in issue. The market capitalisation of Aura Biosciences is US$420.09 million. Aura Biosciences has a price to earnings ratio (PE ratio) of -5.45.

AURA Últimas noticias

Más noticias

Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference

BOSTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ...

26 Noviembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

18 Noviembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

18 Noviembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Noviembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 Noviembre 2024
Edgar (US Regulatory)

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights

Positive Phase 2 End of Study Data with Bel-sar in Early-Stage Choroidal Melanoma; Ongoing Phase 3 CoMpass Trial Recently Received Authorization to Start Enrolling Patients in Europe Multiple...

12 Noviembre 2024
GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

08 Noviembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

29 Octubre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

29 Octubre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.33.735990037368.038.555582227548.21845941CS
4-0.8-8.762322015339.139.5381968768.52976335CS
12-0.5-5.662514156298.8312.378282143589.69377333CS
261.1516.01671309197.1812.37826.81864809.28318614CS
52-0.7-7.75193798459.0312.37826.631754738.56468341CS
156-7.77-48.260869565216.124.835.9912244610.14290714CS
260-5.77-40.921985815614.126.165.9912599310.6795374CS

AURA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Aura Biosciences?
El precio actual de las acciones de Aura Biosciences es US$ 8.33
¿Cuántas acciones de Aura Biosciences están en circulación?
Aura Biosciences tiene 49,951,466 acciones en circulación
¿Cuál es la capitalización de mercado de Aura Biosciences?
La capitalización de mercado de Aura Biosciences es USD 420.09M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Aura Biosciences?
Aura Biosciences ha negociado en un rango de US$ 6.63 a US$ 12.3782 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Aura Biosciences?
El ratio precio/beneficio de Aura Biosciences es -5.45
¿Cuál es la moneda de reporte de Aura Biosciences?
Aura Biosciences presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Aura Biosciences?
El último beneficio anual de Aura Biosciences es USD -76.41M
¿Cuál es la dirección registrada de Aura Biosciences?
La dirección registrada de Aura Biosciences es CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Aura Biosciences?
La dirección del sitio web de Aura Biosciences es www.aurabiosciences.com
¿En qué sector industrial opera Aura Biosciences?
Aura Biosciences opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
INTZIntrusion Inc
US$ 2.167
(381.56%)
189.59M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
HUBCWHub Cyber Security Ltd
US$ 0.035
(250.00%)
2.79M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.95M
LITMSnow Lake Resources Ltd
US$ 1.61
(82.95%)
131.98M
NEUPNeuphoria Therapeutics Inc
US$ 4.11
(-92.30%)
940.73k
VIRXViracta Therapeutics Inc
US$ 0.16
(-32.49%)
9.47M
PRFXPainReform Ltd
US$ 3.48
(-28.98%)
949.52k
AIREreAlpha Tech Corporation
US$ 2.56
(-28.49%)
8.42M
AVGRAvinger Inc
US$ 0.9721
(-24.05%)
2.16M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.95M
RGTIRigetti Computing Inc
US$ 17.08
(10.62%)
305.79M
XTIAXTI Aerospace Inc
US$ 0.03935
(-1.63%)
268M
QSIQuantum Si Inc
US$ 3.585
(66.74%)
256.01M

Discusión

Ver feed completo
prototype_101 prototype_101 5 minutos hace
20 MILLION Shorts Covering Deadline Established June 2025, the gauntlet was put down with the issuance of the new CEO and President Incentive Options being FULLY VESTED in 6 months or June of 2025, this is an UNPRECEDENTED MOVE in the entire history of LWLG!! Normally these types of Incentive Compen
LWLG
52172 52172 6 minutos hace
It will come guaranteed. Patience 2025,6,7 all huge years for amd 
AMD
Hikerbc Hikerbc 6 minutos hace
MULN Stock being attacked by shorters again ? If they roll backup again; then my 7 shares will be zero...............what a disaster this has become.

MULN
meds4life meds4life 7 minutos hace
Nope, not the sitting, but the LYING one
AVXL
52172 52172 8 minutos hace
Coming this week
AMD
Hikerbc Hikerbc 8 minutos hace
Figure Monday we should see an explosive move; hopefully this will spill over to help out AMC ! Share holder of both GME and AMC
AMC GME
JonDoe1 JonDoe1 9 minutos hace
Could be many things. Possibly a little real gold. Who knows? It for sure isn't the 30 million in gold they have claimed to have for years and haven't shown any evidence of years after they PRd that they would.
AABB
TightCoil TightCoil 10 minutos hace
Fannie Mae - All The Way
Freddie Mac - Load Up and Don't Even Think About Looking Back
For Monday 12/30
Break Out Imminent - Push Open The Door
Rally Like Never Before
RALLY SALLY - PUMP - BASHERS ARE LOOSERS
FNMA
mc73 mc73 11 minutos hace
style="font-size: 16px"https://finance.yahoo.com/news/cardio-diagnostics-announces-publication-study-123100950.html
style="font-size: 16px"

style="font-size: 16px"CHICAGO, April 29, 2024--New study finds that Cardio Diagnostics' PrecisionCHD™ test could save health
CDIO
4gh1rx 4gh1rx 11 minutos hace
$AXXA liquidity drying up

$AXXA

_______________________

A long hot journey across open ground stretches ahead for AXXA investors, all knowing that Boris is selfishly hoarding the entire float for himself.
________________________
https://
AXXA
Hestheman47 Hestheman47 11 minutos hace
People like you just don't get it.......done with this convo.
SYIN
flipper44 flipper44 11 minutos hace
That’s kind of antiquated.

Yes upon any approval Media is important.

More importantly is filling in the missing gaps.

1. Who is/are the current companies we have contracts signed for:
A. A complementary basket trial planned and designed?
B.
NWBO
JohnnyRodz JohnnyRodz 12 minutos hace
JohnDope1,"NO GOLD" What is the yellow stuff being heated up in that furnace in the Ezatlan On-Site Labratory? Nacho Cheese perhaps! GTFOH
AABB
cjstocksup cjstocksup 12 minutos hace
https://x.com/elonmuskADO/status/1873418101250985989
Motor-goater Motor-goater 12 minutos hace
Well now we know exactly who sent you!!!! Ha ha ha ha
CNNA
cjstocksup cjstocksup 12 minutos hace
This makes me so angry. Every day now he is sending the Ukraine our money and military equipment etc.
https://x.com/ZelenskyyUa/status/1873454861645197577
Waynewayne Waynewayne 13 minutos hace
Thanks I’m kinda new here now I know!
HMBL
cjstocksup cjstocksup 14 minutos hace
Collection of the craziest 9/11 attack videos that exist. Thread🧵

1. Video shows the terrifying debris cloud engulfing fleeing citizens.
https://x.com/PageOf_History/status/1873360532847436055
stock king 1 stock king 1 15 minutos hace
Meant 2025
LVVV
cjstocksup cjstocksup 16 minutos hace
In 2015, Apple tried to CRUSH Spotify.

• Threatened to remove them from App Store
• Demanded 30% of all revenue
• Blocked their app updates

But Spotify's response was genius.

Here's how a Swedish startup outsmarted the world's biggest compan
JonDoe1 JonDoe1 16 minutos hace
Clearly you missed the point that there is no cash and gold...
AABB
WorstLuck WorstLuck 16 minutos hace
A different CEO would not have made ENTA’s compounds better.

Assuming that it was reasonable to develop NASH compounds, I'm curious what your thoughts are on if/how they could have killed that program more efficiently. (I don't have any insights on that particular program and won't h
ENTA
cjstocksup cjstocksup 18 minutos hace
https://x.com/BGatesIsaPyscho/status/1873299604080607330
janice shell janice shell 19 minutos hace
lol, no, he did not. But it did go out under his name.
suzuki1a suzuki1a 20 minutos hace
Lodas is just an all around do gooder! He just wants to be right! If this MB shut down tomorrow he’d need MORE medication. And remember he does have trouble with zeros. Was it 2.5 million or was it 2.6 billion!!
COOP

Su Consulta Reciente

NASDAQ
AURA
Aura Biosciences
BIT
VERE
Vanguard Ftse Developed ...
BIT
F14262
Vontobel Financial Produ...
BIT
F06718
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados